Table 3.

Main characteristics of studies including patients with cirrhosis and acute upper gastrointestinal bleeding due to gastric antral vascular ectasia

Ref.	Patients (n)	Cirrhotic patients with overt bleeding (n)	Patients received endoscopic treatment (n)	Endoscopic treatment modality (n)	Failure to control initial overt bleeding, n (%)	Endoscopic sessions needed (n)	GAVE eradication, n (%)	Mortality during follow-up, n (%)	Follow-up period (mo)
Labenz et al[25]	5	3	5	NA-YAG LC	0	2-8	0	0	2-12 (median = 6)
Ikeda et al[16]	5	4	5	EC: NR; HPC: NR	0	NR	0	NR	64.8 (mean)
Dulai et al[26]	744 (26 with GAVE)	7	26	Bipolar EC: 13; HPC: 7; APC: 6	0	Median = 3 (2-5)	0	NR	3-10 (median = 6)
Sato et al[17]	8	5	8	APC	0	Mean = 1.8 (1-3)	6/8 (75%)	NR	28 (mean)
Lecleire et al[27]	30 (17 cirrhotics)	11	30	APC	0	Mean = 2.2	NR	9/17 (53%)	Cirrhotics: 20 (median); Non-cirrhotics: 24 (median)
Fuccio et al[28]	20	4	20	APC	0	Median = 3 (1-10)	14/20 (70%)	8/20 (40%)	1-47 (mean = 25)
Sato et al[29]	34 (32 cirrohtics)	13	34	APC (22); EBL (12)	0	APC: Mean = 2.3 (1-3); EBL: Mean = 3 (2-4)	APC: 7/22 (32%); EBL 11/12 (92%)	9/34 (26%)	APC: 16.6 (mean); EBL: 14.6 (mean)

GAVE: Gastric antral vascular ectasia; LC: Lasercoagulation; EC: Electrocoagulation; NR: Not reported; HPC: Heater probe coagulation; APC: Argon plasma coagulation; EBL: Endoscopic band ligation.